# INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION

> **NCT07415278** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Pamukkale University** · enrollment: 61 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Fluticasone propionate nasal spray
- **DRUG:** Fluticasone propionate-azelastine nasal spray

## Key facts

- **NCT ID:** NCT07415278
- **Lead sponsor:** Pamukkale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2023-10-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07415278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07415278, "INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07415278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*